JP Patent

JP2011507829A — 新規なレベチラセタムの被覆徐放性医薬組成物

Assigned to Alembic Ltd · Expires 2011-03-10 · 15y expired

What this patent protects

【解決手段】 レベチラセタムを含む徐放性医薬組成物。コアが速度制御組成物で被覆された、レベチラセタムを含む被覆徐放性医薬組成物。 【選択図】なし

USPTO Abstract

【解決手段】 レベチラセタムを含む徐放性医薬組成物。コアが速度制御組成物で被覆された、レベチラセタムを含む被覆徐放性医薬組成物。 【選択図】なし

Drugs covered by this patent

Patent Metadata

Patent number
JP2011507829A
Jurisdiction
JP
Classification
—
Expires
2011-03-10
Drug substance claim
No
Drug product claim
No
Assignee
Alembic Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.